Protective and immunological behavior of chimeric yellow fever dengue vaccine (Q38731663)

5 September 2017

Protective and immunological behavior of chimeric yellow fever dengue vaccine (English)

1 reference

5 September 2017

0 references

0 references

1 reference

1 reference

Scott B Halstead

1

1 reference

PubMed ID

26873054

5 September 2017

Philip K Russell

series ordinal

2

1 reference

PubMed ID

26873054

5 September 2017

language of work or name

English

0 references

publication date

9 February 2016

1 reference

5 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

5 September 2017

34

1 reference

5 September 2017

14

1 reference

5 September 2017

1643-1647

1 reference

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

PUBLIC HEALTH. Dengue vaccines at a crossroad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Efficacy of a tetravalent dengue vaccine in children in Latin America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Neutralization and antibody-dependent enhancement of dengue viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Effect of age on outcome of secondary dengue 2 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Epidemiologic studies on Dengue in Santiago de Cuba, 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Research on dengue during World War II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Reduced risk of disease during postsecondary dengue virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Nonstructural Protein 1-Specific Immunoglobulin M and G Antibody Capture Enzyme-Linked Immunosorbent Assays in Diagnosis of Flaviviral Infections in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

An in-depth analysis of original antigenic sin in dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Original antigenic sin in dengue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.02.004

1 reference

5 September 2017

1 reference

PubMed ID

26873054